GH
Guardant Health Inc
167.50$
+1.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
Guardant Health Inc (GH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -58 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -37 | -14 | -14 | -27 | -18 | -6.6 | -17 | -22 | -27 | -4.3 | -14 | 1.3 | -30 | -13 | -23 | -8.1 | -59 | -16 | -63 | -53 | -77 | -29 | -112 | -78 | -91 | -74 | -94 | -78 | -79 | -30 | -94 | -51 | -65 | -63 | -60 | -35 | -26 | -66 | -58 | -185 | |
| 3.7 | 1.2 | 1.2 | 1.3 | 1.4 | 1.4 | 1.6 | 2.0 | 2.2 | 3.2 | 3.5 | 1.3 | 5.6 | 3.3 | 3.8 | 4.4 | 4.6 | 5.0 | 5.6 | 5.5 | 6.1 | 7.2 | 8.8 | 9.8 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 9.4 | 10 | 9.4 | 9.6 | 38 | |
| – | 0.6 | 0.6 | 0.8 | 1.6 | 1.3 | 1.2 | 1.8 | 2.6 | 3.2 | 3.2 | 5.5 | 5.1 | 6.3 | 26 | 55 | 57 | 55 | 35 | 35 | 27 | 25 | 26 | 21 | 24 | 22 | 22 | 22 | 24 | 27 | 27 | 50 | 36 | 38 | 42 | 43 | 43 | 48 | 58 | 191 | |
| 3.3 | – | – | 1.4 | 11 | 1.2 | 1.7 | 1.7 | 2.8 | 3.2 | 2.0 | 5.5 | 6.6 | 6.2 | 26 | 63 | 61 | 55 | 46 | 36 | 27 | 27 | 27 | 26 | 24 | 27 | 46 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.6 | 0.6 | -0.9 | -6.2 | 4.5 | 2.0 | -2.2 | -5.4 | 11 | -7.4 | 5.7 | -19 | -1.5 | -5.5 | -4.6 | -36 | 23 | -17 | 2.3 | -49 | 50 | -27 | 27 | 12 | 18 | -20 | -8.4 | 64 | 7.9 | -54 | -12 | -2.8 | -23 | -20 | -3.1 | 32 | -23 | -14 | -8.4 | |
| 1.8 | 0.5 | 0.5 | 2.8 | 4.2 | 4.0 | 7.3 | 5.9 | 2.9 | 2.7 | 3.0 | 8.4 | 7.1 | 27 | 9.5 | 9.8 | 7.3 | 9.6 | 19 | 22 | 25 | 23 | 23 | 22 | 10 | 7.5 | 6.5 | 2.4 | 4.1 | 6.9 | 5.1 | 4.2 | 19 | 4.5 | 5.6 | 10 | 28 | 5.6 | 12 | 56 | |
| 26 | -45 | -45 | 15 | -96 | 8.5 | 12 | 24 | -198 | 15 | -321 | -36 | 23 | 21 | -326 | -15 | -298 | 124 | 127 | -47 | -267 | 111 | -73 | 41 | 71 | 157 | -241 | 261 | 663 | 28 | -5.1 | -295 | 11 | 303 | -11 | -14 | -905 | 699 | 101 | -119 | |
| – | – | – | – | – | – | – | – | 0.2 | 1.4 | – | – | 2.6 | – | – | – | 1,491 | – | – | – | 12 | – | – | 4.0 | – | 1.0 | 21 | 4.6 | 21 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -7.2 | – | – | -0.2 | – | -0.2 | 1.9 | 355 | 7.0 | -0.7 | -0.7 | 361 | -2.2 | 7.1 | -74 | -1.4 | -7.2 | -1.6 | -1.0 | -1.2 | -4.3 | -1.4 | -1.0 | 6.7 | -3.0 | -3.1 | -1.5 | 7.2 | 1.5 | – | -45 | 7.7 | 53 | 0.0 | 0.0 | 10 | 63 | |
| -0.4 | – | – | 0.0 | -26 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,133 | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.1 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | 5.0 | 0.0 | 0.0 | 397 | 0.0 | -1.4 | 396 | |
| 40 | 53 | 53 | 176 | 0.0 | 1.3 | 41 | 0.8 | 250 | 2.3 | 355 | 6.9 | 3.1 | 1.5 | 361 | 0.8 | 1,047 | -70 | 4.9 | -5.6 | 3.8 | 0.0 | -172 | -19 | 2.3 | -0.9 | 384 | 3.8 | 91 | -1.1 | 5.9 | -2.9 | -2.9 | -67 | 1.6 | 4.3 | 732 | -22 | 23 | 738 | |
| 29 | -5.6 | -5.6 | 164 | -114 | 3.2 | 35 | 3.2 | 26 | 13 | 21 | -27 | -4.0 | 9.0 | 12 | -22 | 690 | 37 | 69 | -106 | -340 | 81 | -358 | -57 | -17 | 82 | 47 | 186 | 676 | -4.4 | -94 | -347 | -59 | 174 | -68 | -46 | -200 | 612 | 66 | 432 | |
| – | -14 | -14 | -29 | -22 | -11 | -24 | -28 | -29 | -7.0 | -17 | -7.1 | -37 | -41 | -33 | -18 | -67 | -26 | -81 | -75 | -102 | -51 | -135 | -100 | -101 | -82 | -101 | -80 | -83 | -37 | -99 | -55 | -83 | -67 | -66 | -46 | -54 | -71 | -70 | -241 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.